INS and stroke disorder: In the GIST-UK study, patients presenting within 24 h of stroke onset randomized to variable-dose glucose–potassium–insulin had significantly reduced plasma glucose concentration and systolic blood pressure but no significant reduction in mortality at 90 days compared with the control group [32].